Midazolam Injection, Solution
Product Images NDC 25021-655

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 25021-655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mid02 0016 01

Chemical structure depicting the molecular formula of midazolam hydrochloride, showing its core fused ring system with chlorine and fluorine substitutions, along with the hydrochloride component.*

FDA Label Image

Mid02 0016 02

Chemical structure diagram showing midazolam and its open-ring form, illustrating the two chemical forms of the active ingredient midazolam hydrochloride.*

FDA Label Image

Mid02 0016 03

A line graph depicting the pH dependence of the open-ring form in water, showing the percentage of open-ring form on the Y-axis and pH values ranging from 2.5 to 5.5 on the X-axis. The curve shows a steep decline in the percentage of open-ring form as pH increases from 2.5 to 5.5.*

FDA Label Image

Mid02 0016 04

Midazolam Injection, USP 2 mg per 2 mL (1 mg per mL) single-dose vial label. The label indicates the product is for intramuscular or intravenous use only, supplied by Sagent Pharmaceuticals. It includes manufacturing details and a barcode for product identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.